There is a newer version of this record available.

Working paper Open Access

Ivermectin for Covid-19

Sparavigna, Amelia Carolina


DataCite XML Export

<?xml version='1.0' encoding='utf-8'?>
<resource xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://datacite.org/schema/kernel-4" xsi:schemaLocation="http://datacite.org/schema/kernel-4 http://schema.datacite.org/meta/kernel-4.1/metadata.xsd">
  <identifier identifierType="DOI">10.5281/zenodo.3911707</identifier>
  <creators>
    <creator>
      <creatorName>Sparavigna, Amelia Carolina</creatorName>
      <givenName>Amelia Carolina</givenName>
      <familyName>Sparavigna</familyName>
      <nameIdentifier nameIdentifierScheme="ORCID" schemeURI="http://orcid.org/">0000-0003-4502-8974</nameIdentifier>
      <affiliation>Politecnico di Torino</affiliation>
    </creator>
  </creators>
  <titles>
    <title>Ivermectin for Covid-19</title>
  </titles>
  <publisher>Zenodo</publisher>
  <publicationYear>2020</publicationYear>
  <subjects>
    <subject>Covid-19</subject>
    <subject>Ivermectin</subject>
    <subject>Hydroxychloroquine</subject>
    <subject>Doxycycline</subject>
  </subjects>
  <dates>
    <date dateType="Issued">2020-06-28</date>
  </dates>
  <language>en</language>
  <resourceType resourceTypeGeneral="Text">Working paper</resourceType>
  <alternateIdentifiers>
    <alternateIdentifier alternateIdentifierType="url">https://zenodo.org/record/3911707</alternateIdentifier>
  </alternateIdentifiers>
  <relatedIdentifiers>
    <relatedIdentifier relatedIdentifierType="DOI" relationType="IsVersionOf">10.5281/zenodo.3893750</relatedIdentifier>
    <relatedIdentifier relatedIdentifierType="URL" relationType="IsPartOf">https://zenodo.org/communities/covid-19</relatedIdentifier>
    <relatedIdentifier relatedIdentifierType="URL" relationType="IsPartOf">https://zenodo.org/communities/zenodo</relatedIdentifier>
  </relatedIdentifiers>
  <rightsList>
    <rights rightsURI="https://creativecommons.org/licenses/by/4.0/legalcode">Creative Commons Attribution 4.0 International</rights>
    <rights rightsURI="info:eu-repo/semantics/openAccess">Open Access</rights>
  </rightsList>
  <descriptions>
    <description descriptionType="Abstract">&lt;p&gt;Discussion of scholar papers published until June 28, 2020,&amp;nbsp; on Ivermectin, and of news that we can find about its use for Covid-19.&amp;nbsp; A list of clinical trials is also given. For what concerns scholar papers, we report among them a preprint posted on 10 June in MedR&amp;chi;iv,&amp;nbsp; which concludes that Ivermectin was associated with lower mortality during treatment of Covid-19.&amp;nbsp; From news, we consider in particular the case of Iquitos,&amp;nbsp; capital city of the Loreto Region in Peru, where, by May 25, Covid-19 cases and deaths had dropped notably.&amp;nbsp;&lt;/p&gt;</description>
    <description descriptionType="Other">Before reading this work, please consider that I am not a physician. I do not suggest the use of ivermectin. I am not touting this drug. This analysis of publications and news about ivermectin is made in the framework of a wider investigation about information concerning drugs used for Covid-19.</description>
  </descriptions>
</resource>
3,929
1,349
views
downloads
All versions This version
Views 3,929656
Downloads 1,349377
Data volume 348.3 MB81.2 MB
Unique views 3,216564
Unique downloads 1,121342

Share

Cite as